-
1
-
-
0033653746
-
Cardiovascular disease in chronic renal insufficiency
-
Levin A, Foley RN. Cardiovascular disease in chronic renal insufficiency. Am J Kidney Dis 2000; 36: S24-S30
-
(2000)
Am J Kidney Dis
, vol.36
-
-
Levin, A.1
Foley, R.N.2
-
2
-
-
20844434983
-
Chronic kidney disease as cause of cardiovascular morbidity and mortality
-
Vanholder R, Massy Z, Argiles A, et al. Chronic kidney disease as cause of cardiovascular morbidity and mortality. Nephrol Dial Transplant 2005; 20: 1048-1056
-
(2005)
Nephrol Dial Transplant
, vol.20
, pp. 1048-1056
-
-
Vanholder, R.1
Massy, Z.2
Argiles, A.3
-
3
-
-
0035989794
-
Cardiovascular disease risk factors in chronic renal insufficiency
-
Sarnak MJ, Coronado BE, Greene T, et al. Cardiovascular disease risk factors in chronic renal insufficiency. Clin Nephrol 2002; 57: 327-335
-
(2002)
Clin Nephrol
, vol.57
, pp. 327-335
-
-
Sarnak, M.J.1
Coronado, B.E.2
Greene, T.3
-
4
-
-
0032838784
-
Pathophysiologic effects of uraemic retention solutes
-
Vanholder R, De Smet R. Pathophysiologic effects of uraemic retention solutes. J Am Soc Nephrol 1999; 10: 1815-1823
-
(1999)
J Am Soc Nephrol
, vol.10
, pp. 1815-1823
-
-
Vanholder, R.1
De Smet, R.2
-
5
-
-
0028297796
-
Uraemic toxicity: The middle molecule hypothesis revisited
-
Vanholder R, De Smet R, Hsu C, et al. Uraemic toxicity: the middle molecule hypothesis revisited. Semin Nephrol 1994; 14: 205-218
-
(1994)
Semin Nephrol
, vol.14
, pp. 205-218
-
-
Vanholder, R.1
De Smet, R.2
Hsu, C.3
-
7
-
-
0017297766
-
Study of the intestinal tyrosine metabolism using stable isotopes and gas chromatography-mass spectrometry
-
Curtius HC, Mettler M, Ettlinger L. Study of the intestinal tyrosine metabolism using stable isotopes and gas chromatography-mass spectrometry. J Chromatogr 1976; 126: 569-580
-
(1976)
J Chromatogr
, vol.126
, pp. 569-580
-
-
Curtius, H.C.1
Mettler, M.2
Ettlinger, L.3
-
8
-
-
0030867709
-
Genetic and environmental factors associated with variation of human xenobiotic glucuronidation and sulfa-tion
-
Burchell B, Coughtrie MW. Genetic and environmental factors associated with variation of human xenobiotic glucuronidation and sulfa-tion. Environ Health Perspect 1997; 105: 739-747
-
(1997)
Environ Health Perspect
, vol.105
, pp. 739-747
-
-
Burchell, B.1
Coughtrie, M.W.2
-
10
-
-
0031786689
-
A sensitive HPLC method for the quantification of free and total p-cresol in patients with chronic renal failure
-
De Smet R, David F, Sandra P, et al. A sensitive HPLC method for the quantification of free and total p-cresol in patients with chronic renal failure. Clin Chim Acta 1998; 278: 1-21
-
(1998)
Clin Chim Acta
, vol.278
, pp. 1-21
-
-
De Smet, R.1
David, F.2
Sandra, P.3
-
11
-
-
0028962014
-
Mechanisms of urae-mic inhibition of phagocyte reactive species production: Characterization of the role of p-cresol
-
Vanholder R, De Smet R, Waterloos MA, et al. Mechanisms of urae-mic inhibition of phagocyte reactive species production: characterization of the role of p-cresol. Kidney Int 1995; 47: 510-517
-
(1995)
Kidney Int
, vol.47
, pp. 510-517
-
-
Vanholder, R.1
De Smet, R.2
Waterloos, M.A.3
-
12
-
-
18744385213
-
P-cresol, a uraemic toxin, decreases endothelial cell response to inflammatory cytokines
-
Dou L, Cerini C, Brunet P, et al. P-cresol, a uraemic toxin, decreases endothelial cell response to inflammatory cytokines. Kidney Int 2002; 62: 1999-2009
-
(2002)
Kidney Int
, vol.62
, pp. 1999-2009
-
-
Dou, L.1
Cerini, C.2
Brunet, P.3
-
13
-
-
0037371201
-
Toxicity of free p-cresol: A prospective and cross-sectional analysis
-
De Smet R, Van Kaer J, Van Vlem B, et al. Toxicity of free p-cresol: a prospective and cross-sectional analysis. Clin Chem 2003; 49: 470-478
-
(2003)
Clin Chem
, vol.49
, pp. 470-478
-
-
De Smet, R.1
Van Kaer, J.2
Van Vlem, B.3
-
14
-
-
42949119698
-
Free p-cresol is associated with cardiovascular disease in hemodialysis patients
-
Meijers BK, Bammens B, De Moor B, et al. Free p-cresol is associated with cardiovascular disease in hemodialysis patients. Kidney Int 2008; 73: 1174-1180
-
(2008)
Kidney Int
, vol.73
, pp. 1174-1180
-
-
Meijers, B.K.1
Bammens, B.2
De Moor, B.3
-
15
-
-
33644872268
-
Free serum concentrations of the protein-bound retention solute p-cresol predict mortality in hemodialysis patients
-
Bammens B, Evenepoel P, Keuleers H, et al. Free serum concentrations of the protein-bound retention solute p-cresol predict mortality in hemodialysis patients. Kidney Int 2006; 69: 1081-1087
-
(2006)
Kidney Int
, vol.69
, pp. 1081-1087
-
-
Bammens, B.1
Evenepoel, P.2
Keuleers, H.3
-
16
-
-
23044487722
-
Gas chromatographic-mass spectrometric analysis for measurement of p-cresol and its conjugated metabolites in uraemic and normal serum
-
de Loor H, Bammens B, Evenepoel P, et al. Gas chromatographic-mass spectrometric analysis for measurement of p-cresol and its conjugated metabolites in uraemic and normal serum. Clin Chem 2005; 51: 1535-1538
-
(2005)
Clin Chem
, vol.51
, pp. 1535-1538
-
-
De Loor, H.1
Bammens, B.2
Evenepoel, P.3
-
17
-
-
33846659447
-
P-cresylsulphate, the main in vivo metabolite of p-cresol, activates leucocyte free radical production
-
Schepers E, Meert N, Glorieux G, et al. P-cresylsulphate, the main in vivo metabolite of p-cresol, activates leucocyte free radical production. Nephrol Dial Transplant 2007; 22: 592-596
-
(2007)
Nephrol Dial Transplant
, vol.22
, pp. 592-596
-
-
Schepers, E.1
Meert, N.2
Glorieux, G.3
-
18
-
-
70350031206
-
The uraemic retention solute p-cresyl sulfate and markers of endothelial damage
-
Meijers BK, Van Kerckhoven S, Verbeke K, et al. The uraemic retention solute p-cresyl sulfate and markers of endothelial damage. Am J Kidney Dis 2009; 54: 891-901
-
(2009)
Am J Kidney Dis
, vol.54
, pp. 891-901
-
-
Meijers, B.K.1
Van Kerckhoven, S.2
Verbeke, K.3
-
19
-
-
58449118342
-
Effective removal of protein-bound uraemic solutes by different convective strategies: A prospective trial
-
Meert N, Eloot S, Waterloos MA, et al. Effective removal of protein-bound uraemic solutes by different convective strategies: a prospective trial. Nephrol Dial Transplant 2009; 24: 562-570
-
(2009)
Nephrol Dial Transplant
, vol.24
, pp. 562-570
-
-
Meert, N.1
Eloot, S.2
Waterloos, M.A.3
-
20
-
-
39449112419
-
Estimating GFR using serum cystatin C alone and in combination with serum creatinine: A pooled analysis of 3,418 individuals with CKD
-
Stevens LA, Coresh J, Schmid CH, et al. Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD. Am J Kidney Dis 2008; 51: 395-406
-
(2008)
Am J Kidney Dis
, vol.51
, pp. 395-406
-
-
Stevens, L.A.1
Coresh, J.2
Schmid, C.H.3
-
21
-
-
0036176161
-
K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification
-
K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39: S1-S266
-
(2002)
Am J Kidney Dis
, vol.39
-
-
-
22
-
-
0036054609
-
Carotid plaques, but not common carotid intima-media thickness, are independently associated with aortic stiffness
-
Zureik M, Temmar M, Adamopoulos C, et al. Carotid plaques, but not common carotid intima-media thickness, are independently associated with aortic stiffness. J Hypertens 2002; 20: 85-93
-
(2002)
J Hypertens
, vol.20
, pp. 85-93
-
-
Zureik, M.1
Temmar, M.2
Adamopoulos, C.3
-
23
-
-
0029087202
-
Assessment of arterial dis-tensibility by automatic pulse wave velocity measurement. Validation and clinical application studies
-
Asmar R, Benetos A, Topouchian J, et al. Assessment of arterial dis-tensibility by automatic pulse wave velocity measurement. Validation and clinical application studies. Hypertension 1995; 26: 485-490
-
(1995)
Hypertension
, vol.26
, pp. 485-490
-
-
Asmar, R.1
Benetos, A.2
Topouchian, J.3
-
24
-
-
0030806999
-
New indices to classify location, severity and progression of calcific lesions in the abdominal aorta: A 25-year follow-up study
-
Kauppila LI, Polak JF, Cupples LA, et al. New indices to classify location, severity and progression of calcific lesions in the abdominal aorta: a 25-year follow-up study. Atherosclerosis 1997; 132: 245-250
-
(1997)
Atherosclerosis
, vol.132
, pp. 245-250
-
-
Kauppila, L.I.1
Polak, J.F.2
Cupples, L.A.3
-
25
-
-
33750606026
-
Confounding: Propensity score adjustment
-
Fitzmaurice G. Confounding: propensity score adjustment. Nutrition 2006; 22: 1214-1216
-
(2006)
Nutrition
, vol.22
, pp. 1214-1216
-
-
Fitzmaurice, G.1
-
26
-
-
3543047979
-
P-cresol, a uraemic retention solute, alters the endothelial barrier function in vitro
-
Cerini C, Dou L, Anfosso F, et al. P-cresol, a uraemic retention solute, alters the endothelial barrier function in vitro. Thromb Haemost 2004; 92: 140-150
-
(2004)
Thromb Haemost
, vol.92
, pp. 140-150
-
-
Cerini, C.1
Dou, L.2
Anfosso, F.3
-
27
-
-
1642480079
-
The uraemic solutes p-cresol and indoxyl sulfate inhibit endothelial proliferation and wound repair
-
Dou L, Bertrand E, Cerini C, et al. The uraemic solutes p-cresol and indoxyl sulfate inhibit endothelial proliferation and wound repair. Kidney Int 2004; 65: 442-451
-
(2004)
Kidney Int
, vol.65
, pp. 442-451
-
-
Dou, L.1
Bertrand, E.2
Cerini, C.3
-
28
-
-
33745725902
-
Acarbose treatment lowers generation and serum concentrations of the protein-bound solute p-cresol: A pilot study
-
Evenepoel P, Bammens B, Verbeke K, et al. Acarbose treatment lowers generation and serum concentrations of the protein-bound solute p-cresol: a pilot study. Kidney Int 2006; 70: 192-198
-
(2006)
Kidney Int
, vol.70
, pp. 192-198
-
-
Evenepoel, P.1
Bammens, B.2
Verbeke, K.3
-
29
-
-
33645231323
-
A multicenter, randomized, double-blind, placebo-controlled, dose-ranging study of AST-120 (Kremezin) in patients with moderate to severe CKD
-
Schulman G, Agarwal R, Acharya M, et al. A multicenter, randomized, double-blind, placebo-controlled, dose-ranging study of AST-120 (Kremezin) in patients with moderate to severe CKD. Am J Kidney Dis 2006; 47: 565-577
-
(2006)
Am J Kidney Dis
, vol.47
, pp. 565-577
-
-
Schulman, G.1
Agarwal, R.2
Acharya, M.3
-
30
-
-
0027249628
-
Suppressive effect of an oral sorbent on the accumulation of p-cresol in the serum of experimental uraemic rats
-
Niwa T, Ise M, Miyazaki T, et al. Suppressive effect of an oral sorbent on the accumulation of p-cresol in the serum of experimental uraemic rats. Nephron 1993; 65: 82-87
-
(1993)
Nephron
, vol.65
, pp. 82-87
-
-
Niwa, T.1
Ise, M.2
Miyazaki, T.3
-
31
-
-
34248194989
-
AST-120, an oral adsorbent, delays the initiation of dialysis in patients with chronic kidney diseases
-
Ueda H, Shibahara N, Takagi S, et al. AST-120, an oral adsorbent, delays the initiation of dialysis in patients with chronic kidney diseases. Ther Apher Dial 2007; 11: 189-195
-
(2007)
Ther Apher Dial
, vol.11
, pp. 189-195
-
-
Ueda, H.1
Shibahara, N.2
Takagi, S.3
-
32
-
-
54249083025
-
AST-120 treatment in pre-dial-ysis period affects the prognosis in patients on hemodialysis
-
Ueda H, Shibahara N, Takagi S, et al. AST-120 treatment in pre-dial-ysis period affects the prognosis in patients on hemodialysis. Ren Fail 2008; 30: 856-860
-
(2008)
Ren Fail
, vol.30
, pp. 856-860
-
-
Ueda, H.1
Shibahara, N.2
Takagi, S.3
-
34
-
-
0142120730
-
Novel risk markers and clinical practice
-
Manolio T. Novel risk markers and clinical practice. N Engl J Med 2003; 349: 1587-1589
-
(2003)
N Engl J Med
, vol.349
, pp. 1587-1589
-
-
Manolio, T.1
|